Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Receives GMP Certification from Brazil's ANVISA 2020-12-28 17:50
First Subject Dosed with Gannex's FXR Agonist ASC42 in a U.S. Phase I Trial 2020-12-28 08:30
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma 2020-12-28 08:00
INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine 2020-12-24 23:12
LycovaryTM Daily provides anti-ageing oxygenation of the ovaries to help women with PMS, painful periods and comfortable menopause transition 2020-12-24 08:00
Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis 2020-12-23 12:30
RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue 2020-12-22 20:38
Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial 2020-12-22 19:18
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004 2020-12-21 23:00
LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA 2020-12-21 22:08
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens 2020-12-21 21:00
Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy 2020-12-21 08:00
Antengene Announces Approval of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM 2020-12-18 15:34
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals 2020-12-18 06:52
dMed Completed a US$100 Million Series C Financing 2020-12-17 13:00
Global UV Cured Resins Market will grow to US$ 7892.70 Mn by 2028 at 8.9% CAGR - says Absolute Markets Insights 2020-12-17 11:00
Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange 2020-12-17 08:19
Covance, LabCorp's Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials 2020-12-17 00:29
EpiVax Reports Record Year for Immunogenicity Screening Toolkit (ISPRI) 2020-12-16 02:15
RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model 2020-12-16 00:42
1 185 186 187 188 189 280